.jpg)
Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Monkeypox Cases in UK Begin to Plateau
Statistics show that the number of people infected with the monkeypox virus is starting to slow down.
Antibody & Protein Engineering
AstraZeneca Suffers Sales Decline for COVID Med Evusheld
A 24 million loss has been reported for the preventative COVID-19 treatment.
Antibody & Protein Engineering
Market Battle for Rare Disease Treatment
Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.
NextGen Therapeutics
Bispecific Antibodies for Solid Tumours
Laura von Schantz, Vice President of Discovery at Alligator Bioscience, leads a discussion on the current and future opportunities of bispecific antibodies for solid tumour treatment.
European Approval for Monkeypox Vaccine
The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.
Antibody & Protein Engineering
Widening the Therapeutic Window: Development of Antibody Drug Conjugates for Solid Tumours
Compared to non-solid tumours, solid tumours are more difficult to treat with conventional therapeutic methods. Antibody drug conjugates – biopharmaceutical drugs designed as a targeted therapy for treating cancer – represent a viable treatment alternative.
Antibody & Protein Engineering
Novartis Withdraws Tislelizumab Submission
Novartis scraps US submission of tislelizumab as a monotherapy for non-small cell lung cancer.
New Speakers Announced: Vaccines Europe Congress 2022
Exciting updates revealed about upcoming Vaccines Europe: In-Person congress happening 29-30 November 2022.
Antibody & Protein Engineering
Blood Test Predicts Presence of Beta-Amyloid in Brain
A study by the National Institute of Ageing found that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain.
US Doubles its Supply of Monkeypox Vaccines
The US government has more than doubled its supply of Monkeypox vaccines amidst rising fears.
NextGen Therapeutics
AstraZeneca Buys T Cell Engager for $100 Million
Pharma giant makes a major investment in improving the standards of care in B cell malignancies.